The role and potential of CD19-targeted chimeric antigen receptor T-cell therapy in systemic sclerosis

Krzysztof Michalak, Gabriela Chlebowska, Oliwia Sędziak, Dariusz Woszczyk

Open source

DOI
10.5114/reum/224664
Published
2026-07-10
Container
Rheumatology
Publisher
Termedia Sp. z.o.o.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5114/reum/224664,
  title = {The role and potential of CD19-targeted chimeric antigen receptor T-cell therapy in systemic sclerosis},
  author = {Krzysztof Michalak and Gabriela Chlebowska and Oliwia Sędziak and Dariusz Woszczyk},
  year = {2026},
  journal = {Rheumatology},
  doi = {10.5114/reum/224664},
  url = {https://doi.org/10.5114/reum/224664}
}

RIS

TY  - JOUR
TI  - The role and potential of CD19-targeted chimeric antigen receptor T-cell therapy in systemic sclerosis
AU  - Krzysztof Michalak
AU  - Gabriela Chlebowska
AU  - Oliwia Sędziak
AU  - Dariusz Woszczyk
PY  - 2026
JO  - Rheumatology
DO  - 10.5114/reum/224664
UR  - https://doi.org/10.5114/reum/224664
ER  - 

APA

Michalak, K., Chlebowska, G., Sędziak, O., & Woszczyk, D. (2026). The role and potential of CD19-targeted chimeric antigen receptor T-cell therapy in systemic sclerosis. Rheumatology. https://doi.org/10.5114/reum/224664

Source records